Skip to content

Glaukos GKOS Gross Profit

Gross Profit at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$15.96B+9.8%
AbbVie logo
AbbVieABBV
$10.78B+15.4%
Boston Scientific logo
Boston ScientificBSX
$3.61B+12.6%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$735.4M+8.3%
Exelixis logo
ExelixisEXEL

Other financials

Income statement

See full
Revenue$150.6M+41.2%
Operating income-$19.9M+4.0%
Net income-$19.8M-9.0%
EPS (diluted)-$0.34-6.3%

Balance sheet

See full
Cash & equivalents$104.2M-8.8%
Total debt$105.9M-1.7%
Total equity$670.9M-12.2%
Total assets$893.3M-7.5%

Cash flow

See full
Operating cash flow-$12.5M+32.4%
CapEx$4.0M+104%
Free cash flow-$16.5M+19.4%

Valuation

See full
Market cap$7.68B+12.3%
Enterprise value$7.68B+12.5%
P/S13.9×-3.0×

Profitability

See full
Gross margin78.1%+2.3pp
Operating margin-36.1%+24.3pp
Net margin-34.3%+4.8pp
FCF margin-13.2%-3.9pp

Returns & leverage

See full
Return on equity-26.4%+11.1pp
Debt / equity0.2×0.0×
Current ratio5.4×-1.1×

Where this comes from

Calculated from Glaukos’s reported figures.

The official record: Glaukos’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Glaukos's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Glaukos's gross profit?
Glaukos (GKOS) reported gross profit of $117.23M in Q1 2026.
How has Glaukos's gross profit changed year-over-year?
Glaukos's gross profit increased by 42.4% year-over-year, from $82.35M to $117.23M.
What is the long-term trend for Glaukos's gross profit?
Over 4 years (2021 to 2025), Glaukos's gross profit has grown at a 14.9% compound annual growth rate (CAGR), from $227.38M to $395.63M.
What does gross profit mean?
Gross profit is the residual profit after deducting the cost of goods sold from total revenue. It serves as a primary indicator of the company's core manufacturing efficiency and pricing power.